Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	56
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	39
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	33
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	30
Treatments and challenges in advanced prostate cancer	27
Role of PSMA PET/CT in imaging and management of prostate cancer	26
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	26
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	24
Editorial introductions	24
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	23
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	21
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	19
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	17
Psycho-oncology interventions focusing on fatigue and sleep disturbances	17
Harnessing dendritic cells for innovative therapeutic cancer vaccines	17
Safety of assisted reproductive techniques in gynecological cancer patients	16
New hopes in relapsed refractory primary central nervous system lymphoma	16
Editorial introductions	16
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	16
Editorial introductions	16
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	15
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	15
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	14
How to prevent human papillomavirus-related oropharyngeal cancer?	14
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	14

Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	14
Indications and technique of minimally invasive surgery in early-stage cervical cancer	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	12
The evolving landscape of bispecific antibodies in the treatment of lung cancer	12
Biomarkers and immunotherapy: where are we?	12
Open questions on vorasidenib	12
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	12
Editorial introductions	12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Editorial introductions	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	11
Recent advances in precision medicine for acute myeloid leukemia	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	11
Circulating tumor DNA in breast cancer: a biomarker for patient selection	10
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	10
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	10
Liquid biopsy in brain tumors: moving on, slowly	10
Lung cancer screening in never smokers	10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	9
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	9
Editorial introductions	9
Pathology and new insights in central nervous system lymphomas	9
Current role and indications of minimally invasive surgery in gynecologic oncology	8
Desmoid tumors: who, when and how to treat?	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
Editorial introductions	8
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
Application of single-port techniques in endometrial cancer	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Artificial intelligence in lung cancer: from diagnosis to therapy	8
A new comprehensive and stratified concept for supportive care in cancer patients	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	8
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
How to support parenting in patients with cancer and co-parents? From research to practice	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Pathologic diagnosis of lung cancer – recent developments	7
Editorial introductions	7
Potential application of artificial intelligence in cancer therapy	7
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
New therapies for brain metastases: an update	7
Editorial introductions	7
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	7
Breast surgery after neoadjuvant therapy	7
Editorial introductions	7

The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Preclinical glioma models in neuro-oncology: enhancing translational research	7
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	7
Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer	7
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
Richter transformation: biological insights, diagnostic challenges and emerging therapies	6
Polyamine metabolism in prostate cancer	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6
Treatment of radiation-associated angiosarcoma	6
Cellular therapies in sarcoma and other solid tumors	6
Editorial introductions	6
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	6
How to monitor the side effects of treatments in cancer patients	6
Targeting cancer stem cell pathways for lung cancer therapy	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Precision, personalization, and quality of life for patients with lymphoma	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Achievements of international rare cancers networks and consortia in the neuro-oncology field	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
Preoperative immunotherapy for head and neck cancers: state of art	5
HIV-related lymphomas	5
Clinical management of brain tumors in pregnancy	5
How to treat localized Hodgkin lymphoma?	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Patient-proxy agreement on health-related quality of life assessment in cancer patients	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Vascular complications in patients with brain tumors	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Early Detection of Cancers in the Era of Precision Oncology	4
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	4
State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma	4
Immunotherapy of sarcomas with modified T cells	4
Molecular genotyping in medullary thyroid cancer	4
Optimizing the prescription doses and tolerability of systemic therapy in head and neck cancer patients	4
Future of sentinel node biopsy in ovarian cancer	4
Update of antibody–drug conjugates for hematological malignancies	4
Targeting exon 20 insertion mutations in lung cancer	4
New trends in supportive care of head and neck cancers	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	4
How to treat advanced Hodgkin lymphoma?	4
Editorial introductions	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Editorial introductions	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
High-risk smoldering myeloma – a case for early intervention?	4
Recent advances in immunotherapy for small cell lung cancer	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Editorial introductions	3
Action against thoracic cancers: recent achievements and perspectives	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Editorial: Psychological interventions in oncology: advances and challenges	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3
New strategies for the treatment of breast cancer with leptomeningeal metastasis	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
CIC-DUX4 sarcomas	3
Editorial Introductions	3
Use of staging for sex cord stromal tumours	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	3
New targeted treatments for advanced sarcomas	3
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	3

Treatment of lung cancer in pregnant women	3
Evolving systemic management of urothelial cancers	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Challenges in the management of relapsed germ cell tumors	3
Editorial: Advanced care planning	3
Cancer-associated thrombosis: what is new?	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Targeting androgen receptors in patients with metastatic breast cancer	3
New treatments for desmoid tumors	3
New treatment strategies for primary central nervous system lymphoma	3
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists	3
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Advances in the treatment of light chain amyloidosis	3
Precision medicine in extended adjuvant endocrine therapy for breast cancer	3
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
The role of menin inhibitors in acute myeloid leukemia	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
First line treatments in primary central nervous system lymphomas in young patients	2
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	2
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	2
Emerging therapies in Ewing sarcoma	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Treatment approaches for older Hodgkin lymphoma patients	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decades	2
Sarculator: how to improve further prognostication of all sarcomas	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	2
The role of next-generation sequencing in acute myeloid leukemia	2
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Editorial introductions	2
Interventions for children of parents with cancer: an overview	2
Immuno-oncology in the daily practice	2
Circulating tumor DNA in B cell lymphomas	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
Perioperative immunotherapy for nonsmall cell lung cancer	2
Advance care planning in oncology: a scoping review and some recommendations	2
Management of epilepsy in brain tumor patients	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2